# OnCo record nct05102006 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05102006/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05102006", "NCT05102006" ;
  schema:name "A Phase Ib/II Clinical Study of LBL-007 in Combination With Toripalimab in Treatment of Advanced Malignant Tumors"@en ;
  schema:description "A phase 1/2 trial of Alcestobart run by Nanjing Leads Biolabs Co.,Ltd, completed."@en ;
  schema:url <https://onco.cc/trials/nct05102006/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05102006> ;
  onco:status "completed" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:drugs <https://onco.cc/drugs/alcestobart/> ;
  onco:companies <https://onco.cc/companies/nanjing-leads-biolabs/> .
